Regulation of the haemostatic activity of plasma von Willebrand factor

血浆血管性血友病因子止血活性的调节

• 批准号: nhmrc : 1110219
• 负责人: Prof Philip Hogg
• 金额: $ 58.74万
• 依托单位: Australian National University
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2016
• 资助国家: 澳大利亚
• 起止时间: 2016-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/regulation-haemostatic-activity-willebrand-factor/663119
• 关键词: Regulation; haemostatic; activity; plasma; von

Our genes encode proteins that perform the tasks of life. Most proteins are chemically modified after they are made to control how, when, and where they function. Prof Hogg discovered a new chemical modification of proteins that is important in health and disease. He will apply this discovery to develop new diagnostics and therapies for heart attacks and stroke. Prof Hogg is one of the few Australians to take new diagnostics and therapies developed in the lab to evaluation in patients.

我们的基因编码蛋白质，执行生命的任务。大多数蛋白质在被制造出来后都会被化学修饰，以控制它们如何，何时以及在哪里发挥作用。霍格教授发现了一种新的蛋白质化学修饰，对健康和疾病很重要。他将应用这一发现开发新的诊断和治疗心脏病发作和中风的方法。霍格教授是少数几个将实验室开发的新诊断和疗法用于患者评估的澳大利亚人之一。